CD24 Expression is an Independent Prognostic Marker in Cholangiocarcinoma

This publication has 42 references indexed in Scilit:

• Akt expression may predict favorable prognosis in cholangiocarcinoma
  Journal of Gastroenterology and Hepatology, 2006
• CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma
  Cancer Letters, 2006
• The Metastasis-Associated Gene CD24 Is Regulated by Ral GTPase and Is a Mediator of Cell Proliferation and Survival in Human Cancer
  Cancer Research, 2006
• Cytoplasmic CD24 Expression in Colorectal Cancer Independently Correlates with Shortened Patient Survival
  Clinical Cancer Research, 2005
• CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer
  The Prostate, 2003
• Hepatectomy With Portal Vein Resection for Hilar Cholangiocarcinoma
  Annals of Surgery, 2003
• The role of overexpression and gene amplification of cyclin D1 in intrahepatic cholangiocarcinoma
  Journal of Hepatology, 2001
• Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis
  British Journal of Cancer, 2000
• Hilar Cholangiocarcinoma
  Annals of Surgery, 1998
• Radiation Studies on B Cell Differentiation Marker CD24/SCLC Cluster-4 Antigen Expressing and Non-expressing Lung Cancer Cell Lines and Mouse Fibroblasts
  International Journal of Radiation Biology, 1995